ASHLEY MIDDLETON: Open Payments
NPI 1669071114 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 69 payments from 15 companies in 2025. Trend: 2023 $1,869 · 2024 $1,791 · 2025 $1,352
Food & beverage: $1,352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $263 |
| Janssen Biotech, Inc. | 12 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $234 |
| Lilly USA, LLC | 8 | $150 |
| Ferring Pharmaceuticals Inc. | 6 | $143 |
| Aimmune Therapeutics, Inc. | 2 | $63 |
| GENZYME CORPORATION | 2 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| PFIZER INC. | 2 | $38 |
| Celltrion USA Inc. | 1 | $29 |
Products named: TREMFYA, RINVOQ, ENTYVIO, REBYOTA, OMVOH, DUPIXENT, EOHILIA, ZENPEP.
Industry payments across PA — which companies pay providers there.
